Degeneration of the cerebellar granule cell layer in transgenic mice expressing genes of human foamy virus

Neuropathology and Applied Neurobiology

Volumn 24, Issue 1, 1998, Pages 36-43

  Lampe, J ^a   Marino, S ^a   Rethwilm, A ^b   Aguzzi, A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cerebellum; Human foamy virus; Immunohistochemistry; Neurodegeneratien; Transgenic mice

Indexed keywords

GENE PRODUCT; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; BLINDNESS; BRAIN CORTEX; CEREBELLUM DEGENERATION; GENE EXPRESSION; GRANULE CELL; HIPPOCAMPUS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PURKINJE CELL; QUADRIPLEGIA; SPUMA VIRUS; TRANSGENIC ANIMAL;

ANIMALS; CEREBELLAR DISEASES; GENE DOSAGE; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HUMANS; MICE; MICE, TRANSGENIC; NERVE DEGENERATION; PHENOTYPE; SPUMAVIRUS; TRANSGENES; VIRAL STRUCTURAL PROTEINS;

EID: 0031929574     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1998.00086.x     Document Type: Article

References (25)

1. Achong BG, Mansell PW, Epstein MA, Clifford P. An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 1971; 46: 299-307
2. Aguzzi A, Bothe K, Anhauser I, Horak I, Rethwilm A, Wagner EF. Expression of human foamy virus is differentially regulated during development in transgenic mice. New Biol 1992; 4: 225-37
3. Aguzzi A, Marino S, Tschopp R, Rethwilm A. Regulation of expression and pathogenic potential of human foamy virus in vitro and in transgenic mice. Curr Top Microbiol Immunol 1996; 206: 243-73
4. Aguzzi A, Wagner EF, Netzer KO, Bothe K, Anhauser I, Rethwilm A. Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice. Am J Pathol 1993; 142: 1061-71
5. Baunach G, Maurer B, Hahn H, Kranz M, Rethwilm A. Funcional analysis of human foamy virus accessory reading frames. J Virol 1993; 67: 5411-8
6. Bothe K, Aguzzi A, Lassmann H, Rethwilm A, Horak I. Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science 1991; 253: 555-7
7. Brandner S, Isenmann S, Raeber A et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996; : 339-43
8. Cameron KR, Birchall SM, Moses MA. Isolation of foamy virus from patient with dialysis encephalopathy. Lancet 1978; 2: 796
9. Gourdou I, Mabrouk K, Harkiss G et al. Neurotoxicity in mice due to cysteine-rich parts of visna virus and HIV-1 Tat proteins. C R Acad Sci III 1990; 311: 149-55
10. Hahn H, Baunach G, Brautigam S et al. Reactivity of primate sera to foamy virus Gag and Bet proteins. J Gen Virol 1994; 75: 2635-44
11. Heneine W, Musey VC, Sinha SD et al. Absence of evidence for human spumaretrovirus sequences in patients with Graves' disease. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 99-101
12. Keller A, Partin KM, Lochelt M, Bannert H, Flugel RM, Cullen BR. Characterization of the transcriptional trans activator of human foamy retrovirus. J Virol 1991; 65: 2589-94
13. Lagaye S, Vexiau P, Morozov V et al. Human spumaretro-virus-related sequences in the DNA of leukocytes from patients with Graves disease. Proc Natl Acad Sci USA 1992; 89: 10070-4
14. Mahnke C, Lochelt M, Bannert H, Flugel RM. Specific enzyme-linked immunosorbent assay for the detection of antibodies to the human spumavirus. J Virol Meth 1990; 29: 13-22
15. Marino S, Kretschmer C, Brandner S et al. Activation of HIV transcription by human foamy virus in transgenic mice. Lab Invest 1995; 73: 103-10
16. Rethwilm A. Regulation of foamy virus gene expression. Curr Top Microbiol Immunol 1995; 193: 1-24
17. Rethwilm A, Erlwein O, Baunach G, Maurer B, ter Meulen V. The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. Proc Natl Acad Sci U S A 1991; 88: 941-5
18. Rosener M, Hahn H, Kranz M, Heeney J, Rethwilm A. Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. J Med Virol 1996; 48: 222-6
19. Schweizer M, Neumann Haefelin D. Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. Virol 1995; 207: 577-82
20. Schweizer M, Turek R, Hahn H et al. Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses 1995; 11: 161-70
21. Schweizer M, Turek R, Reinhardt M, Neumann Haefelin D. Absence of foamy virus DNA in Graves' disease. AIDS Res Hum Retroviruses 1994; 10: 601-5
22. Stancek D, Stancekova Gressnerova M, Janotka M, Hnilica P, Oravec D. Isolation and some serological and epidemiological data on the viruses recovered from patients with subacute thyroiditis de Quervain. Med Microbiol Immunol Berl 1975; 161: 133-44
23. Tschopp RR, Brandner S, Marino S et al. Analysis of the determinants of neurotropism and neurotoxicity of HFV in transgenic mice. Virol 1996; 216: 338-46
24. Venkatesh LK, Chinnadurai G. The carboxy-terminal transcription enhancement region of the human spumaretro-virus transactivator contains discrete determinants of the activator function. J Virol 1993; 67: 3868-76
25. Young D, Samuels J, Clarke JK. A foamy virus of possible human origin isolated in BHK-21 cells. Arch Gesamte Virusforsch 1973; 42: 228-34